Japan’s approval of the world’s first self-amplifying mRNA (saRNA) vaccine for COVID-19 has ignited a firestorm of controversy. Critics have dubbed this new technology the “third atomic bomb,” drawing a provocative parallel to the country’s traumatic past. The vaccine, called ARCT-154 or Kostaive, received approval in November 2023 and was introduced on October 1, 2024. […]
